Background {#s1}
==========

There are growing numbers of people with chronic conditions with a particularly rapid rise in the number with multiple care needs. The complex needs of people with multiple chronic conditions require the development of delivery systems that bring together a range of professionals and skills from both the cure and care sectors to meet those needs. Despite this, service delivery has developed in ways that have tended to fragment care, both within and between sectors, through for example structural and financial barriers dividing providers at the primary/secondary care and at the health and social care interface; distinct organizational and professional cultures; and differences in terms of governance and accountability \[[@r1]\].

A substantial number of evaluations have been carried out of interventions designed to improve the integration or coordination of care. A systematic review based on 21 reviews and 85 primary studies \[[@r2]\] showed that many of these initiatives were effective in improving care, though many fewer resulted in a reduction in healthcare costs ([Table 1](#tb001){ref-type="table"}). One of the conclusions of this and other reviews is that the effectiveness of attempts to provide better integrated care is highly dependent on the context in which the intervention takes place. Interventions cannot be seen separated from the context in which they are introduced, and this has been an important guiding principle in the evaluation described in this paper.

In response to concerns that the needs of the aging population for well-integrated care were increasing, the UK Department of Health for England announced in 2008 that a number of 'Integrated Care Pilots' would be established. Healthcare purchasers and providers were invited to submit proposals for innovative approaches to providing better integrated care \[[@r3]\]. There was no specification as to the form that such integration should take, or client groups who should receive the intervention. There were over 100 applications, and after a two-stage selection process, the Department of Health selected 16 pilots. The localities of selected pilots and the main focus of each are described in [Annex 1](#app1){ref-type="app"}.

A team from RAND Europe, Ernst and Young LLP and the University of Cambridge were appointed to carry out a three-year evaluation that was augmented by the inclusion in the evaluation of experts from the Nuffield Trust. The evaluation aims to answer the following questions:

-   What approaches to integration have been employed by the pilots?

-   What approaches to integration work well and in what contexts?

-   Who benefits from integration, in what ways, and with what consequences for equity?

-   What resources are required to make integration succeed and how can these be efficiently used?

-   In delivering integrated care in the English National Health Service, what policies and practices are: most likely to deliver the intended outcome, most capable of being implemented and most acceptable to patients, users, clinicians, managers and the wider public.

A mixed methods approach was adopted including interviews with staff and patients, non-participant observation of meetings, structured written feedback from sites, questionnaires to service users and staff, and analysis of routinely collected hospital utilisation data for patients/users who had been recruited into the pilots.

Analytical framework {#s1a}
--------------------

Our approach to understanding the context in which integration takes place is based on two classifications relating to structure and function. At the start of the evaluation these classifications were deliberately general to avoid focusing too early on very specific approaches to integrated care. We wanted to accommodate the fact that that the pilots themselves were still refining their approaches.

a\) Structure

Integration can be seen as occurring at three levels \[[@r4], [@r5]\]

-   *Micro-level integration activities.* These promote integration among individual practitioners within a single organisation (e.g. between doctors and nurses in a primary care practice setting).

-   *Meso-level integration activities.* These promote integration among practitioners working in different organisations (e.g. between GPs and specialists). This might include co-location of services, which could occur with or without *macro-level activities*, such as pooled budgets.

-   *Macro-level integration activities.* These promote integration designed to facilitate organisation-to-organisation working, e.g. across different sectors. These may include policy agreements and financial arrangements. Examples of these are pooled budgets or joint budget holding between health and social care services, employment of care staff in a single organisation, or structural changes to facilitate work across two or more organisations.

b\) Function

Integration can be classified \[[@r6]\] in terms of

-   *Organisational integration*, where organisations are brought together by mergers or by structural change.

-   *Service integration*, where different clinical services or support/back-office functions are integrated.

-   *Clinical integration,* where the focus is on care for a particular condition.

This classification will guide our analysis of the data, and our testing of the various hypotheses which arose during the course of the study. These included hypotheses that integrated care would lead to the development of new organisational structures to support integration, changes in staff roles, increased staff job satisfaction, fewer unscheduled emergency hospital admissions, reduced length of hospital stay, increased patient satisfaction, and reduced cost.

It should be noted that the evaluation was designed and funded prior to the appointment of the integrated care pilots, so these hypotheses were developed during the first six months of the evaluation as a result of detailed interaction with the sites. This unusual research design allowed for the evaluation to be tailored to the aims of the sites which were not known at the time the evaluation team was appointed.

Research methods {#s2}
================

Principles guiding the evaluation {#s2a}
---------------------------------

The evaluation described here adopts the approach of the 'embedded evaluator'. The evaluation activities form a distinct strand within the Integrated Care Pilot programme, helping to co-produce the successful delivery of the programme, rather than a completely separate study focused solely on contributing to the scientific understanding of integrated care. However, it is equally important that the evaluation contributes to scientific understanding and that it generates valid and independent evidence to support decision-making in the future. The approach combines systematically collecting and synthesizing evidence from across all the pilots together with a deeper investigation of a smaller number of pilots in order to gain more detailed understanding of the structures, processes, costs and outcomes of integration.

Integrated Care Pilots use a variety of integrating activities (ranging from influencing, creating incentives, sharing information, creating new information systems and so forth) and have a variety of objectives (including improving the effectiveness and efficiency of services, enhancing patient reported outcomes and delivering measurable health improvements. In this context, the research approach is multi-method in order to understand both the activities pursued and the outcomes achieved. The evaluation is based on six approaches to data collection and analysis:

1.  Systematic qualitative data collection from all sites (through a 'Living Document' which is a semi-structured document completed regularly by each pilot site).

2.  In-depth case studies of six sites ('Deep Dives') including interviews with staff and patients/service users and non-participant observation of meetings \[see Section Systematic qualitative data collection from all sites (the 'Living Document') for more on why we decided to use case studies\].

3.  Difference in differences analysis of data on hospital utilization comparing patients/service users enrolled in pilots with control data.

4.  Data from patient questionnaires.

5.  Data from staff questionnaires.

6.  Analysis of costs (combining data from qualitative case studies and quantitative data on service utilization).

Evaluation involves a number of activities leading to an exercise of judgement \[[@r7], [@r8]\]. In evaluating the complex set of activities which broadly sit under the heading of 'Integrated Care Pilots' we also seek to arrive at judgements which are seen to be legitimate by the stakeholders involved \[[@r9]\]. This requirement for legitimacy is one of the many ways in which 'pure' research is distinct from evaluation. This legitimacy potentially involves five steps (similar to those identified by Scriven \[[@r10]\]):

1.  Understand from those delivering the pilots and from those funding the initiative the criteria they consider to be applicable.

2.  Agree the standards and intended outcomes that are applicable.

3.  Gather data relating to these standards and outcomes.

4.  Assess the contribution made by the agency/activity in achieving these standards and outcomes.

5.  Form a performance audit judgement.

These steps protect the evaluators from the accusation of being arbitrary or otherwise non-rational, but an important part of the logic of the evaluation is to develop a set of hypotheses based on the 'theory of change' offered up by the pilots themselves. Implicitly or explicitly, many evaluations of complex interventions use a 'theory of change' approach. These evaluations aim not only to understand the contribution made by a programme or activity to achieving outcomes, but also to interrogate evidence and communicate findings to support both learning and accountability. Our approach takes as its starting point the argument of Weiss \[[@r11], p. 66--67\] that: "*The concept of grounding evaluation in theories of change takes for granted that social programmes are based on explicit or implicit theories about how and why the programme will work...The evaluation should surface those theories and lay them out in as fine detail as possible, identifying all the assumptions and sub-assumptions built into the programme. The evaluators then construct methods for data collection and analysis to track the unfolding assumptions. The aim is to examine the extent to which programme theories hold...the evaluation should show which of the assumptions underlying the programme are best supported by the evidence.*"

In this sense, 'theories of change' is a guiding approach rather than a methodology, and its successful delivery requires harnessing a range of methodologies, such as those outlined elsewhere in this paper. Our 'theories of change' approach has five precepts. First the approach requires us to not only look at the outcomes of the programme but to pay equal attention to processes. This contrasts with more classical evaluation approaches which tend to look at outcomes first and then to look for evidence to support attribution. Secondly, the approach requires a more 'embedded' evaluator where the evaluator works closely with policy makers, practitioners and end users to understand and elaborate a sometimes changing theory of change. Without losing their independence, successful evaluators will understand the world of the policy makers, practitioners and service users, including an understanding of what motivates their behaviour. Thirdly, the approach requires an ability to reconstruct and represent the sequence of events connecting actions to each other and how these contributed to the outcomes identified, reconstructing at least the sequence of events and statistical co-variations, but preferably also identifying the causal mechanisms at work. Fourthly, the approach is sensitive to the possibility that during the life of a programme or intervention, initial theories of change may alter in response to learning or to exogenous events and that the evaluation needs to capture these changing understandings and actions. Fifthly, it will also be sensitive to the fact that different and potentially conflicting theories of change might be simultaneously pursued within any one programme. Collectively, these precepts describe an interest not only in *causal effects* (what happens when an independent variable changes) but also *causal mechanisms* (what connects causes to their effects); not only what officials say they do but what the evidence *shows* they do; and not only what contribution stories practitioners tell themselves and others but also what really *contributes* to benefit. Therefore, theory building and testing is an important part of the approach taken but it does not start with *a priori* theoretical claims or assumptions.

Systematic qualitative data collection from all sites (the 'Living Document') {#s2b}
-----------------------------------------------------------------------------

The Living Document involves semi-structured data collection from all Integrated Care Pilots at approximately six-monthly intervals during the evaluation. A lead person is designated in each site to collate responses in the Living Document, but in most cases, this individual draws on a variety of sources in collating responses, and there is an expectation that the views of a wide range of stakeholders will be represented in the completion of the document. The data collected in the Living Document are organised into a series of broad questions:

-   Development of the pilot and background information. Questions identifying the background, purpose and background setting of the pilot.

-   Who is doing what? Identifying the main people and organisations involved, and their roles in implementing the pilot.

-   Processes---identifying the intended processes, and processes which have been implemented so far.

-   Outputs and outcomes achieved so far.

-   Progress to date. A description of progress to date, an assessment of progress against plan, and an outline of what has facilitated/prevented progress.

-   Sustainability. Assessment of how arrangements to promote sustainability are progressing.

-   Attribution of changes to specific initiatives relating to the pilot. An assessment of how much difference is really being made by the pilot itself, in the context of other health policy initiatives which are taking place concurrently.

-   Resource implications of the pilot. Without attempting to provide a precise monetary value to the outcomes of the pilot, an assessment of the costs of the pilot, and whether benefits might have been achieved more easily in other ways.

After each round of data collection, data from the Living Document are analysed, and feedback is given in two ways. First, limited feedback is given to each site, including the opportunity to specify where more detailed information is needed in future rounds of Living Document completion. Second, the overall themes emerging from the Living Document are analysed, and these are fed back in a single document to all sites after each round of data collection. This analysis also contributes to 'learning events' (conferences and teleconferences to address different issues of relevance to pilots) which are being run by the Department of Health throughout the pilot period, and subsequent rounds of the Living Document are adapted in light of feedback from the sites.

In-depth case studies of six sites ('Deep Dives') {#s2c}
-------------------------------------------------

We selected a range of types of pilots for in-depth case study to reflect the range of approaches in the pilots and then select a sample from these reflecting the need for variety and site's ability to support a more detailed evaluation. For the depth case studies in six sites, we will structure the evaluation using an approach that combines logic modeling with process mapping of the patient journey. These methods will complement each other in creating a full picture of the integration pathways. Logic models \[[@r12]\] provide a brief summary of the key elements of an intervention (or programme, or project) and organize inputs, processes, outputs and outcomes systematically. They facilitate a focus on the causal links in the chain connecting the allocation of resources to the intended outcomes. As such, they are well suited to supporting an understanding the 'theory of change' underpinning the activity and simultaneously identifying the sorts of data that might support or weaken that theory \[[@r11]\].

This approach will provide both a way to describe and communicate the different interventions but also to provide a basis for what, causally, is happening. It will provide the framework for understanding how the inputs of a pilot are related to its outcomes and impacts. They are especially helpful in developing a shared understanding of a process between stakeholders and serve as a reference point for stakeholders in the initiative or programme. Process mapping the service user experience, by contrast, involves understanding the motivations, experiences and outcomes of the various interactions between the service user and the (integrated) service \[[@r13]\].

Using these case studies, we will address the following questions:

-   What approaches to integration have been employed by the pilots? This will provide a richer description of models than is possible in the overall national evaluation by exploring experiences, motivations, relationships, processes and costs in more detail.

-   What approaches to integration work well and in what contexts? This will generate data linking putative causes to observed effects i.e. understanding causal mechanisms.

-   Who benefits from integration and in what ways (what definitions are there of 'success')? This will identify how benefits are distributed and with what implications for equality.

-   What resources are required to make integration succeed and how can these be efficiently used? This will identify the descriptive categories of costs, establishing their dimensions, estimating overall costs, and suggesting how generalisable these findings might be. The Living Document will help identify what types of costs become apparent at various stages of development of a project.

-   How the development of integrated care is facilitated or impeded by other current policies, e.g. payment by results, practice-based commissioning etc.

From these analyses, we aim to identify what policies and practices are most suitable (i.e. fit for purpose and likely to deliver the intended outcome); most feasible (i.e. capable of being implemented given the existing architecture of delivery and accountability); and most acceptable (i.e. likely to generate the support of the people who use services, clinicians and other professionals, managers and the wider public).

There will be three key data collection methods: semi-structured interviews with professionals and patients/service users, documentary analysis, non-participant observation of meetings. The qualitative data collection in the Deep Dive sites will also be used to collect data for the economic analysis (see below).

Interviews with staff will concentrate on the experience of delivering care, interactions with other professional groups and organizations within the Integrated Care Pilot, and understanding of implications for the wider care system. Interviews with patients and users will focus on the patient/user journey and experience and its relationship to changes in the Integrated Care Pilots.

Service utilisation {#s2d}
-------------------

In analysing data on service utilisation, we will focus principally on hospital admissions as a key variable, as many of the sites have a focus on reducing such admissions.

Data will be taken from Hospital Episode Statistics (HES), both for outpatient referrals, accident and emergency attendances and inpatient stays. These will enable analyses of changes in a number of measures of hospital use including overall rates of emergency admissions, admissions for 'ambulatory sensitive' conditions (see [Annex 2](#app2){ref-type="app"}), and length of stay. We derived the list of ambulatory sensitive conditions from AHRQ \[[@r14]\] and Purdy et al. \[[@r15]\].

Information will be available for the individuals enrolled in any intervention, and also for the whole populations of general practices which are participating in the Integrated Care Pilot. The data will be at person level but anonymised so that the research team cannot identify sensitive personal information or individual identities. The NHS Information Centre for Health and Social Care will act a trusted third party to handle any confidential information and create the anonymised linked fields for use by the research team.

One of the key challenges in undertaking analyses of changes in hospital use for complex interventions is that individuals may be selected for an intervention because they have a high use of health services. The problem is that any subsequent fall in utilisation in this group may simply be due to regression to the mean---that is people reverting to a normal level of use irrespective of the intervention. One way round this is to use an approach that allows us to standardise for differences in the risk of future admissions.

First, we will assess the impact of the intervention on individuals enrolled in the Integrated Care Pilots. Information on the prior patterns of diagnoses and hospital utilisation will be used to stratify cases according to the risk of admission. The actual level of utilisation before and after the agreed starting point in each pilot will be compared. In this way we will be able to track levels of hospital use for cohorts of people for 2--3 years before they became part of the pilot. We will then test for subsequent change and compare results by risk strata.

In addition, we will undertake a more sophisticated analysis to create a matched 'control group' constructed by identifying individuals within national data. These control cases will be matched on a number of variables including risk of admission (or other hospital use); major diseases recorded; history of hospital use; and characteristics of the area of residence, such as levels of deprivation. Matching will be conducted using propensity scoring techniques \[[@r16]\] and prognostic scoring techniques \[[@r17]\]. Trends in hospital use within the groups of selected control cases will then be used as a test of observed differences in those enrolled in the Integrated Care Pilots.

Second, we will quantify the effect of the interventions on wider groups of patients (e.g. practice populations) by matching utilization data to that from to similar practice populations in national HES datasets. The population level analysis will assess whether the intervention might not only have an impact on individual patients but also upon the wider population.

Both of these approaches to analysis are required as there might be an impact of the interventions on individuals (e.g. a reduction in admissions) which could not be demonstrated in the wider population. This might be because resources were simply redistributed between groups at equal risk of admission, or because the numbers enrolled in the pilots were too small to show an effect on the wider population.

Sample size calculations suggest that few of the Integrated Care Pilot sites will enroll sufficient numbers for data from individual sites to be analysed. We therefore intend to pool data from sites which have similar aims and are providing broadly comparable interventions. It is not possible to say which sites will provide data that can be pooled, as all sites are still developing their interventions. However, it looks likely, for example, that several sites will be using a form of case management of high-risk patients with the aim of reducing hospital admission, and we will be able to pool data from such sites. Data will also be analysed on primary and social care utilisation (from patient questionnaires). However, these data are being collected primarily for the economic analysis, as none of the sites has reduction in primary care utilisation as their main goal.

Our analysis strategy is built around a generalized difference-of-differences regression approach at the person level. Regression models appropriate for each of the outcome measures (e.g. emergency admissions) will be developed. These may be Poisson models, negative binomial models, or gamma models as required by the form of the measure. Each individual will contribute one or more time periods to the dataset in both the pre- and post-intervention periods. Non-intervention controls will come from routinely collected national data. These models will use covariates including basic demographics and historical utilization to control for potential differences between the intervention and control cases. Person level random effects will also be included in the models to adjust standard errors for the repeated measures within person.

In addition to the traditional covariate adjustment in the difference-of-differences model we will use propensity score based methods. In a combined dataset of intervention cases and non-intervention controls a propensity score model will be fitted that uses available covariates to predict intervention vs. control status. The predicted treatment status probabilities can be used to match intervention and control cases. We may also use the propensity scores to produce analysis weights which can be combined with covariate adjustment to support 'doubly robust' estimation of intervention effects \[[@r18]\]. Doubly robust estimation combined with difference-of-differences modeling will provide intervention effect estimates that control for both observed differences between intervention and control groups as well controlling for unobserved but fixed person characteristics.

The aim of identifying risk-matched controls and using propensity score analysis is to allow so far as possible for unmeasured patient and system effects and therefore to increase our ability to draw conclusions about likely cause and effect from what inevitably remains observational data.

Questionnaires for service users {#s2e}
--------------------------------

We are conducting two surveys to assess the experience of service users in 11 of the 16 pilots. The survey is being administered in autumn/winter 2009 and will be repeated on the same sample of service users in autumn 2010. The questionnaire was developed using the intended outcomes identified by pilot sites in their applications to join the scheme. This identified a number of domains which were common to most pilots and were therefore included in the questionnaire. These were:

-   Communication with primary care doctors and nurses.

-   Organisation and coordination of care.

-   Care planning.

-   Assessment of care from social services.

-   Arrangements following discharge from hospital.

-   Frequency of certain critical events (notes unavailable, test duplicated, wrong medication or wrong dose of medication prescribed, no follow-up arrangements after hospital discharge).

In addition, a question on service usage was included to contribute to the analysis of health service costs (see below). The questionnaire is available from the authors.

In selecting items to represent these domains, we drew questions were possible from existing validated instruments. In particular we drew a substantial number of questions from the English National GP patient survey which is currently sent annually to 5.5 million randomly sampled patients ([www.gp-patient.co.uk](www.gp-patient.co.uk)). By matching the socio-demographic and health questions to this survey also, we will be able to conduct a difference in differences analysis with individual control patients drawn from responders to the national survey.

For five pilot sites it was not appropriate to collect patient information using this questionnaire because of the nature of the intervention and/or the population group targeted by the intervention (for example, some pilots were focusing on end of life care). These sites are excluded from this part of the evaluation.

Questionnaires are being sent to up to 500 service users in each site. Where the site has identified more that 500 service users by autumn 2009, a random sample of 500 will be taken. Where fewer than 500 service users have been identified by March 2010, the questionnaire is sent to them all. Where a site is enrolling patients/service users sequentially during autumn 2009/spring 2010, all patients receive a questionnaire until 500 have been enrolled. Those individuals who receive a questionnaire in autumn 2009/spring 2010 will receive a second questionnaire in autumn 2010. For all service users, the site identifies the start data of any intervention, so that we can determine whether questionnaires returned have been completed before or after the start of the intervention.

Questionnaires for health and social care staff {#s2f}
-----------------------------------------------

We are conducting two cross-sectional staff surveys within the 16 pilot sites, involving health and social care staff (including community nurses, GPs and social workers), in spring 2010, and repeated in spring 2011. The staff questionnaire has substantial sections for free text to allow staff to describe their experience of the pilot in more detail, and these sections will be transcribed for qualitative analysis. The questionnaire includes sections on:

-   Job changes since the introduction of the Integrated Care Pilot.

-   Perceived changes to the care that patients/service users receive.

-   Changes in communication within and between employing organisations.

-   Changes in team working.

-   Communication with other health and social care staff.

-   Job satisfaction, ability to deliver high quality care.

For the staff survey the targeted sample size is 50 staff from each site. The first are staffs who are closely involved in the development of the pilot (e.g. employed by the pilot). There are expected to be between 5 and 15 of these per site. The additional 35--45 will be sent to stratified random samples of practitioners whose work might be altered by the pilot---e.g. GPs, community nurses, social workers.

Economic analysis {#s2g}
-----------------

There are two approaches to the economic evaluation. The first is to estimate costs in order to provide decision-makers in the health and social care systems with a basis for understanding the categories and potential range of costs associated with the Integrated Care Pilots. This will provide a sense of how much the approach might cost if it were implemented elsewhere. An important part of this will be through data collection in the Deep Dive sites where we will use the logic model, process maps, key informant interviews, and documentary evidence to produce estimates of the costs of providing integrated care. This will enable us to identify the categories of cost and the scale of resources required to deliver different models of integration. We aim to produce a clear understanding of the main categories of cost (staff by grade, equipment, building, travel etc.), the likely range of costs within each category, and subsequently estimate best, worst and most likely case scenarios.

We will also distinguish between 'set-up' costs and 'running costs', although in a fluid, adaptive and improving system it may be difficult to draw this distinction. For both of these we need to distinguish between the costs associated with participating in the DH programme (including, for example, participation in events, reporting, contributing to the national evaluation) and the costs solely required to deliver the integrated care programme. We also aim to gather data through time that can show how costs have altered in response to actual service delivery or in order to overcome changing circumstances etc. We propose only to look at costs internal to the health and social care system (including private sector partners) but we will be aware that costs could potentially be externalised onto service users and carers and we will ask service users and staff to comment on their sense of the types and magnitudes of these costs.

Across the Integrated Care Pilots where we are collecting quantitative data on hospital utilisation, data on hospital admissions and length of stay will be costed using standard NHS costs, and included in the controlled difference in differences analysis described in above.

Conclusion {#s3}
==========

Selecting evaluation frameworks always involves a degree of compromise to meet conflicting demands within a finite budget. We have opted to balance the collection of data from across all the pilots with more detailed data from six Deep Dive sites. We have also opted to focus the evaluation on what the pilots themselves told us they were seeking to achieve. The benefit of this is that we will be in a position to provide an evaluation which is grounded firmly in what the pilots are seeking to do. This increases the chances that findings will be acceptable and used. However, it also means that some theoretical propositions will be under-explored and that attention may be directed more towards intended outcomes than unintended outcomes. However, we are satisfied that this risk is managed by independent data collection (for example on service utilisation, service user surveys and staff surveys) and by the iterative way of working with those responsible for running each project.

In planning to assess the evidence produced by this evaluation, we have been influenced by the principles of realistic evaluation \[[@r19]\] in which the mechanism (the intervention) acts in context to produce the outcome. If there is a single lesson from previous evaluations of attempts to integrate or coordinate care, it is that the context in which an intervention is introduced is crucially important to its success or failure. So, in this evaluation, we have committed substantial resources to the qualitative evaluation, knowing that these analyses will be critical to interpreting the results of quantitative analyses. Our approach is to understand not only the 'dose, frequency and effect' but to identify the way pilots learn, respond and evolve and to take into account the expectations and motivations of staff and patients to understand how complex and evolving projects might have lessons for others seeking to do related things in different contexts. Policy makers, professionals, managers, carers and patients are all part of an emergent process. We do not expect to measure precisely all effects but we do expect to understand the likely scope of benefits and the scale of efforts required, to contribute to the analysis of health service interventions and so reduce decision-makers' uncertainties about integrated care.

This evaluation will produce a portfolio of evidence including interviews, surveys, cost estimations and service utilisation data aimed at strengthening the evidence base for integrated care, and in particular identifying the context in which interventions are likely to be effective. These data will support a series of evaluation judgements but it is important to recognise that they cannot be arrived at by simple aggregation of data \[[@r20]\]. Rather, the process locates the new data within the existing body of research and forms judgements about what is added and how compelling this additional evidence is, thus reducing uncertainties about the role of integrated care in improving the efficient and effective delivery of healthcare.

The study was funded by the Department of Health and is being carried out by RAND Europe and Ernst and Young. The views expressed are those of the authors and not of the Department of Health and does not constitute any form of assurance, legal opinion or advice. RAND Europe and Ernst and Young shall have no liability to any third party in respect to the contents of this article.
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Annex 1 Summary of focus of individual Integrated Care Pilot sites

  Pilot                                                 Main focus (some sites have other objectives also)
  ----------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Bournemouth and Poole                                 Structured support for people with dementia in the community
  Cambridge                                             Support for end of life care in the community; reduction in unnecessary admissions to hospital
  Church View Medical Practice                          Improved support for people with long-term conditions at risk of admission to hospital
  Cumbria                                               Improved support for people with long-term conditions at risk of admission to hospital
  Durham Dales                                          Providing integrated primary and secondary care service for acutely ill people, improved community services, moving specialist services into the community, identification of people at risk of fuel poverty
  Northamptonshire Integrated Care Partnership (NENE)   Improved support for people with long-term conditions at risk of admission to hospital
  Newquay                                               Structured support for people with dementia in the community
  Norfolk                                               Improved support for people with long-term conditions at risk of admission to hospital
  North Tyneside                                        Screening of patients at risk of falls: assessment by multi-disciplinary team
  Northumbria                                           Improved support for people with COPD with a history of admissions to hospital
  North Cornwall                                        Mental health care
  Principia Partners in Health                          Improved support for people with long-term conditions at risk of admission to hospital. Second stream has specific focus on people with COPD
  Tameside and Glossop                                  Structured programme of identification and management of people at risk of cardio-vascular disease (CVD). Second stream of work for people with established CVD
  Torbay                                                Improved discharge planning. Support for GPs from community geriatrician. Improved support for people in the community with dementia, COPD and congestive cardiac failure. Falls prevention programme
  Tower Hamlets                                         Structured care for people with diabetes
  Wakefield Integrated Substance Misuse Service         Implementation of 'dashboard' routinely feeding back performance data for services providing care for people with substance misuse

###### 

Annex 2 List of 'ambulatory care sensitive conditions' (ACSCs) and associated ICD-10 codes (derived from AHRQ \[[@r14]\] and Purdy et al. \[[@r15]\]). These are admissions for diagnoses that in principle may be preventable by good quality primary care

  Ambulatory care sensitive condition              ICD-10 code   Definition
  ------------------------------------------------ ------------- ---------------------------------------------------------------------------------------------
  Alcohol-related disease                          F10           Mental and behavioural disorders due to use of alcohol
  Angina                                           I20           Angina pectoris
  Angina                                           I240          Coronary thrombosis not resulting in myocardial infarction
  Angina                                           I248          Other forms of acute ischemic heart disease
  Angina                                           I249          Acute ischemic heart disease, unspecified
  Angina                                           I25           Chronic ischemic heart disease
  Angina                                           R072          Precordial pain
  Asthma                                           J45           Asthma
  Asthma                                           J46           Status asthmaticus
  Atrial fibrillation and flutter                  I471          Supra-ventricular tachycardia
  Atrial fibrillation and flutter                  I479          Paroxysmal tachycardia, unspecified
  Atrial fibrillation and flutter                  I495          Sick sinus syndrome
  Atrial fibrillation and flutter                  I498          Other specified cardiac arrhythmias
  Atrial fibrillation and flutter                  I499          Cardiac arrhythmia, unspecified
  Atrial fibrillation and flutter                  R000          Tachycardia, unspecified
  Atrial fibrillation and flutter                  R002          Palpitations
  Atrial fibrillation and flutter                  R008          Other and unspecified abnormalities of heart beat
  Cellulitis                                       I891          Lymphangitis
  Cellulitis                                       L010          Impetigo \[any organism\] \[any site\]
  Cellulitis                                       L011          Impetiginization of other dermatoses
  Cellulitis                                       L020          Cutaneous abscess, furuncle, and carbuncle of face
  Cellulitis                                       L021          Cutaneous abscess, furuncle, and carbuncle of neck
  Cellulitis                                       L022          Cutaneous abscess, furuncle, and carbuncle of trunk
  Cellulitis                                       L023          Cutaneous abscess, furuncle, and carbuncle of buttock
  Cellulitis                                       L024          Cutaneous abscess, furuncle, and carbuncle of limb
  Cellulitis                                       L028          Cutaneous abscess, furuncle, and carbuncle of other sites
  Cellulitis                                       L029          Cutaneous abscess, furuncle, and carbuncle, unspecified
  Cellulitis                                       L03           Cellulitis
  Cellulitis                                       L04           Acute lymphadenitis
  Cellulitis                                       L080          Pyoderma
  Cellulitis                                       L088          Other specified local infections of skin and subcutaneous tissue
  Cellulitis                                       L089          Local infection of skin and subcutaneous tissue, unspecified
  Cellulitis                                       L88           Pyoderma gangrenosum
  Cellulitis                                       L980          Pyogenic granuloma
  Congestive heart failure                         I110          Hypertensive heart disease with (congestive) heart failure
  Congestive heart failure                         I130          Hypertensive heart and renal disease with (congestive) heart failure
  Congestive heart failure                         I132          Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
  Congestive heart failure                         I255          Ischemic cardiomyopathy
  Congestive heart failure                         I50           Heart failure
  Congestive heart failure                         J81           Pulmonary edema
  Constipation                                     K590          Constipation
  Convulsions and Epilepsy                         G253          Myoclonus
  Convulsions and Epilepsy                         G40           Epilepsy
  Convulsions and Epilepsy                         G41           Status epilepticus
  Convulsions and Epilepsy                         R56           Convulsions, not elsewhere classified
  COPD                                             J40           Bronchitis, not specified as acute or chronic
  COPD                                             J41           Simple and mucopurulent chronic bronchitis
  COPD                                             J42           Unspecified chronic bronchitis
  COPD                                             J43           Emphysema
  COPD                                             J44           Other chronic obstructive pulmonary disease
  COPD                                             J47           Bronchiectasis
  COPD                                             J20           Acute bronchitis
  Dehydration and gastroenteritis                  A020          Salmonella gastroenteritis
  Dehydration and gastroenteritis                  A04           Other bacterial intestinal infections
  Dehydration and gastroenteritis                  A059          Bacterial food-borne intoxication, unspecified
  Dehydration and gastroenteritis                  A072          Cryptosporidiosis
  Dehydration and gastroenteritis                  A080          Rotaviral enteritis
  Dehydration and gastroenteritis                  A081          Acute gastroenteropathy due to Norwalk agent
  Dehydration and gastroenteritis                  A082          Adenoviral enteritis
  Dehydration and gastroenteritis                  A083          Other viral enteritis
  Dehydration and gastroenteritis                  A084          Viral intestinal infection, unspecified
  Dehydration and gastroenteritis                  A085          Other specified intestinal infections
  Dehydration and gastroenteritis                  A09           Diarrhea and gastroenteritis of presumed infectious origin
  Dehydration and gastroenteritis                  E86           Volume depletion
  Dehydration and gastroenteritis                  K520          Gastroenteritis and colitis due to radiation
  Dehydration and gastroenteritis                  K521          Toxic gastroenteritis and colitis
  Dehydration and gastroenteritis                  K522          Allergic and dietetic gastroenteritis and colitis
  Dehydration and gastroenteritis                  K528          Other specified non-infective gastroenteritis and colitis
  Dehydration and gastroenteritis                  K529          Non-infective gastroenteritis and colitis, unspecified
  Dementia                                         F00           Dementia in Alzheimer\'s disease
  Dementia                                         F01           Vascular dementia
  Dementia                                         F02           Dementia in other diseases classified elsewhere
  Dementia                                         F03           Unclassified dementia
  Dementia                                         R54           Senility
  Dental conditions                                A690          Necrotizing ulcerative stomatitis
  Dental conditions                                K02           Dental caries
  Dental conditions                                K03           Other diseases of hard tissues of teeth
  Dental conditions                                K04           Diseases of pulp and periapical tissues
  Dental conditions                                K05           Gingivitis and periodontal diseases
  Dental conditions                                K06           Other disorders of gingiva and edentulous alveolar ridge
  Dental conditions                                K08           Other disorders of teeth and supporting structures
  Dental conditions                                K098          Other cysts of oral region, not elsewhere classified
  Dental conditions                                K099          Cyst of oral region, unspecified
  Dental conditions                                K12           Stomatitis and related lesions
  Dental conditions                                K13           Other diseases of lip and oral mucosa
  Diabetes complications                           E100          Insulin-dependent diabetes mellitus with coma
  Diabetes complications                           E101          Insulin-dependent diabetes mellitus with ketoacidosis
  Diabetes complications                           E102          Insulin-dependent diabetes mellitus with renal complications
  Diabetes complications                           E103          Insulin-dependent diabetes mellitus with ophthalmic comps
  Diabetes complications                           E104          Insulin-dependent diabetes mellitus with neurological comps
  Diabetes complications                           E105          Insulin-dependent diabetes mellitus with periph circ comps
  Diabetes complications                           E106          Insulin-dependent diabetes mellitus with other spec comps
  Diabetes complications                           E107          Insulin-dependent diabetes mellitus with multiple comps
  Diabetes complications                           E108          Insulin-dependent diabetes mellitus with unspec comps
  Diabetes complications                           E110          Non-insulin-dependent diabetes mellitus with coma
  Diabetes complications                           E111          Non-insulin-dependent diabetes mellitus with ketoacidosis
  Diabetes complications                           E112          Non-insulin-dependent diabetes mellitus with renal comps
  Diabetes complications                           E113          Non-insulin-dependent diabetes mellitus with ophthalm comps
  Diabetes complications                           E114          Non-insulin-dependent diabetes mellitus with neuro comps
  Diabetes complications                           E115          Non-insulin-dependent diabetes mellitus with periph circ comp
  Diabetes complications                           E116          Non-insulin-dependent diabetes mellitus with other spec comp
  Diabetes complications                           E117          Non-insulin-dependent diabetes mellitus with multiple comps
  Diabetes complications                           E118          Non-insulin-dependent diabetes mellitus with unspec comps
  Diabetes complications                           E120          Malnutrition-related diabetes mellitus with coma
  Diabetes complications                           E121          Malnutrition-related diabetes mellitus with ketoacidosis
  Diabetes complications                           E122          Malnutrition-related diabetes mellitus with renal comps
  Diabetes complications                           E128          Malnutrition-related diabetes mellitus with unspec comps
  Diabetes complications                           E130          Other specified diabetes mellitus with coma
  Diabetes complications                           E131          Other specified diabetes mellitus with ketoacidosis
  Diabetes complications                           E132          Other specified diabetes mellitus with renal complications
  Diabetes complications                           E133          Other specified diabetes mellitus with ophthalmic comps
  Diabetes complications                           E134          Other specified diabetes mellitus with neurological comps
  Diabetes complications                           E135          Other specified diabetes mellitus with periph circ comps
  Diabetes complications                           E136          Other specified diabetes mellitus with other spec comps
  Diabetes complications                           E137          Other specified diabetes mellitus with multiple comps
  Diabetes complications                           E138          Other specified diabetes mellitus with unspecified comps
  Diabetes complications                           E140          Unspecified diabetes mellitus with coma
  Diabetes complications                           E141          Unspecified diabetes mellitus with ketoacidosis
  Diabetes complications                           E142          Unspecified diabetes mellitus with renal complications
  Diabetes complications                           E143          Unspecified diabetes mellitus with ophthalmic complications
  Diabetes complications                           E144          Unspecified diabetes mellitus with neurological comps
  Diabetes complications                           E145          Unspecified diabetes mellitus with periph circulatory comps
  Diabetes complications                           E146          Unspecified diabetes mellitus with other specified comps
  Diabetes complications                           E147          Unspecified diabetes mellitus with multiple complications
  Diabetes complications                           E148          Unspecified diabetes mellitus with unspecified complications
  Dyspepsia and other stomach function disorders   K21           Gastroesophageal reflux disease
  Dyspepsia and other stomach function disorders   K30           Dyspepsia
  Ear, nose and throat infections                  H66           Suppurative and unspecified otitis media
  Ear, nose and throat infections                  H67           Otitis media in diseases classified elsewhere
  Ear, nose and throat infections                  J02           Acute pharyngitis
  Ear, nose and throat infections                  J03           Acute tonsillitis
  Ear, nose and throat infections                  J040          Acute laryngitis
  Ear, nose and throat infections                  J06           Acute upper respiratory infections of multiple and unspecified sites
  Ear, nose and throat infections                  J312          Chronic pharyngitis
  Fractured proximal femur                         S720          Fracture of neck of femur
  Fractured proximal femur                         S721          Pertrochanteric fracture
  Fractured proximal femur                         S722          Subtrochanteric fracture
  Gangrene                                         R02           Gangrene, not elsewhere classified
  Hypertension                                     I10           Essential (primary) hypertension
  Hypertension                                     I119          Hypertensive heart disease without (congestive) heart failure
  Hypertension                                     I129          Hypertensive renal disease without renal failure
  Hypertension                                     I139          Hypertensive heart and renal disease, unspecified
  Hypokalaemia                                     E876          Hypokalemia
  Influenza and pneumonia                          A481          Legionnaires\' disease
  Influenza and pneumonia                          A70           Chlamydia psittaci infection
  Influenza and pneumonia                          J10           Influenza due to identified influenza virus
  Influenza and pneumonia                          J11           Influenza, virus not identified
  Influenza and pneumonia                          J120          Adenoviral pneumonia
  Influenza and pneumonia                          J121          Respiratory syncytial virus pneumonia
  Influenza and pneumonia                          J122          Parainfluenza virus pneumonia
  Influenza and pneumonia                          J128          Other viral pneumonia
  Influenza and pneumonia                          J129          Viral pneumonia, unspecified
  Influenza and pneumonia                          J13           Pneumonia due to Streptococcus pneumoniae
  Influenza and pneumonia                          J14           Pneumonia due to Hemophilus influenzae
  Influenza and pneumonia                          J153          Pneumonia due to streptococcus, group B
  Influenza and pneumonia                          J154          Pneumonia due to other streptococci
  Influenza and pneumonia                          J157          Pneumonia due to Mycoplasma pneumoniae
  Influenza and pneumonia                          J159          Bacterial pneumonia, unspecified
  Influenza and pneumonia                          J160          Chlamydial pneumonia
  Influenza and pneumonia                          J168          Pneumonia due to other specified infectious organisms
  Influenza and pneumonia                          J18           Pneumonia, organism unspecified
  Iron-deficiency anaemia                          D460          Refractory anemia without sideroblasts, so stated
  Iron-deficiency anaemia                          D461          Refractory anemia with sideroblasts
  Iron-deficiency anaemia                          D463          Refractory anemia with excess of blasts with transformation
  Iron-deficiency anaemia                          D464          Refractory anemia, unspecified
  Iron-deficiency anaemia                          D501          Sideropenic dysphagia
  Iron-deficiency anaemia                          D508          Other iron deficiency anemias
  Iron-deficiency anaemia                          D509          Iron deficiency anemia, unspecified
  Iron-deficiency anaemia                          D510          Vitamin B12 deficiency anemia due to intrinsic factor deficiency
  Iron-deficiency anaemia                          D511          Vitamin B12 deficiency anemia due to selective vitamin B12 malabsorption with proteinuria
  Iron-deficiency anaemia                          D512          Transcobalamin II deficiency
  Iron-deficiency anaemia                          D513          Other dietary vitamin B12 deficiency anemia
  Iron-deficiency anaemia                          D518          Other vitamin B12 deficiency anemias
  Iron-deficiency anaemia                          D520          Dietary folate deficiency anemia
  Iron-deficiency anaemia                          D521          Drug-induced folate deficiency anemia
  Iron-deficiency anaemia                          D528          Other folate deficiency anemias
  Iron-deficiency anaemia                          D529          Folate deficiency anemia, unspecified
  Iron-deficiency anaemia                          D531          Other megaloblastic anemias, not elsewhere classified
  Iron-deficiency anaemia                          D571          Sickle-cell anemia without crisis
  Iron-deficiency anaemia                          D580          Hereditary spherocytosis
  Iron-deficiency anaemia                          D581          Hereditary elliptocytosis
  Iron-deficiency anaemia                          D590          Drug-induced autoimmune hemolytic anemia
  Iron-deficiency anaemia                          D591          Other autoimmune hemolytic anemias
  Iron-deficiency anaemia                          D592          Drug-induced non-autoimmune hemolytic anemia
  Iron-deficiency anaemia                          D599          Acquired hemolytic anemia, unspecified
  Iron-deficiency anaemia                          D601          Transient acquired pure red cell aplasia
  Iron-deficiency anaemia                          D608          Other acquired pure red cell aplasias
  Iron-deficiency anaemia                          D609          Acquired pure red cell aplasia, unspecified
  Iron-deficiency anaemia                          D610          Constitutional aplastic anemia
  Iron-deficiency anaemia                          D611          Drug-induced aplastic anemia
  Iron-deficiency anaemia                          D640          Hereditary sideroblastic anemia
  Iron-deficiency anaemia                          D641          Secondary sideroblastic anemia due to disease
  Iron-deficiency anaemia                          D642          Secondary sideroblastic anemia due to drugs and toxins
  Iron-deficiency anaemia                          D643          Other sideroblastic anemias
  Iron-deficiency anaemia                          D644          Congenital dyserythropoietic anemia
  Iron-deficiency anaemia                          D648          Other specified anemias
  Migraine/acute headache                          G43           Migraine
  Migraine/acute headache                          G440          Cluster headache syndrome
  Migraine/acute headache                          G441          Vascular headache, not elsewhere classified
  Migraine/acute headache                          G443          Chronic posttraumatic headache
  Migraine/acute headache                          G444          Drug-induced headache, not elsewhere classified
  Migraine/acute headache                          G448          Other specified headache syndromes
  Migraine/acute headache                          R51           Headache
  Nutritional deficiency                           E40           Kwashiorkor
  Nutritional deficiency                           E41           Nutritional marasmus
  Nutritional deficiency                           E42           Marasmic kwashiorkor
  Nutritional deficiency                           E43           Unspecified severe protein-energy malnutrition
  Nutritional deficiency                           E550          Rickets, active
  Nutritional deficiency                           E643          Sequelae of rickets
  Other vaccine-preventable diseases               A35           Other tetanus
  Other vaccine-preventable diseases               A36           Diphtheria
  Other vaccine-preventable diseases               A37           Whooping cough
  Other vaccine-preventable diseases               A80           Acute poliomyelitis
  Other vaccine-preventable diseases               B05           Measles
  Other vaccine-preventable diseases               B06           Rubella \[German measles\]
  Other vaccine-preventable diseases               B161          Acute hepatitis B with delta-agent (coinfection) without hepatic coma
  Other vaccine-preventable diseases               B169          Acute hepatitis B without delta-agent and without hepatic coma
  Other vaccine-preventable diseases               B180          Chronic viral hepatitis B with delta-agent
  Other vaccine-preventable diseases               B181          Chronic viral hepatitis B without delta-agent
  Other vaccine-preventable diseases               B26           Mumps
  Other vaccine-preventable diseases               G000          Hemophilus meningitis
  Other vaccine-preventable diseases               M014          Rubella arthritis
  Pelvic inflammatory disease                      N70           Salpingitis and oophoritis
  Pelvic inflammatory disease                      N73           Other female pelvic inflammatory diseases
  Pelvic inflammatory disease                      N74           Female pelvic inflammatory disorders in diseases classified elsewhere
  Perforated appendix                              K350          Acute appendicitis with generalized peritonitis
  Perforated appendix                              K351          Acute appendicitis with peritoneal abscess
  Perforated/bleeding ulcer                        K20           Esophagitis
  Perforated/bleeding ulcer                        K210          Gastroesophageal reflux disease with esophagitis
  Perforated/bleeding ulcer                        K219          Gastroesophageal reflux disease without esophagitis
  Perforated/bleeding ulcer                        K221          Ulcer of esophagus
  Perforated/bleeding ulcer                        K226          Gastroesophageal laceration-hemorrhage syndrome
  Perforated/bleeding ulcer                        K250          Acute with hemorrhage
  Perforated/bleeding ulcer                        K251          Acute with perforation
  Perforated/bleeding ulcer                        K252          Acute with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K254          Chronic or unspecified with hemorrhage
  Perforated/bleeding ulcer                        K255          Chronic or unspecified with perforation
  Perforated/bleeding ulcer                        K256          Chronic or unspecified with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K260          Acute with hemorrhage
  Perforated/bleeding ulcer                        K261          Acute with perforation
  Perforated/bleeding ulcer                        K262          Acute with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K264          Chronic or unspecified with hemorrhage
  Perforated/bleeding ulcer                        K265          Chronic or unspecified with perforation
  Perforated/bleeding ulcer                        K266          Chronic or unspecified with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K270          Acute with hemorrhage
  Perforated/bleeding ulcer                        K271          Acute with perforation
  Perforated/bleeding ulcer                        K272          Acute with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K274          Chronic or unspecified with hemorrhage
  Perforated/bleeding ulcer                        K275          Chronic or unspecified with perforation
  Perforated/bleeding ulcer                        K276          Chronic or unspecified with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K280          Acute with hemorrhage
  Perforated/bleeding ulcer                        K281          Acute with perforation
  Perforated/bleeding ulcer                        K282          Acute with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K284          Chronic or unspecified with hemorrhage
  Perforated/bleeding ulcer                        K285          Chronic or unspecified with perforation
  Perforated/bleeding ulcer                        K286          Chronic or unspecified with both hemorrhage and perforation
  Perforated/bleeding ulcer                        K920          Hematemesis
  Perforated/bleeding ulcer                        K921          Melena
  Perforated/bleeding ulcer                        K922          Gastrointestinal hemorrhage, unspecified
  Peripheral vascular disease                      I73           Other peripheral vascular diseases
  Tuberculosis                                     A15           Respiratory tuberculosis, bacteriologically and histologically confirmed
  Tuberculosis                                     A16           Respiratory tuberculosis, not confirmed bacteriologically or histologically
  Tuberculosis                                     A17           Tuberculosis of nervous system
  Tuberculosis                                     A18           Tuberculosis of other organs
  Tuberculosis                                     A19           Miliary tuberculosis
  Urinary infection                                N10           Acute tubulo-interstitial nephritis
  Urinary infection                                N11           Chronic tubulo-interstitial nephritis
  Urinary infection                                N12           Tubulo-interstitial nephritis, not specified as acute or chronic
  Urinary infection                                N136          Pyonephrosis
  Urinary infection                                N151          Renal and perinephric abscess
  Urinary infection                                N159          Renal tubulo-interstitial disease, unspecified
  Urinary infection                                N30           Cystitis
  Urinary infection                                N390          Urinary tract infection, site not specified

The above table contains all conditions and codes listed in Purdy et al. (2009) tables 3 and 4 except the following: 'Failure to thrive' and 'low birth weight' are excluded as they are purely paediatric conditions.'Angina' codes R073, R074, Z034, Z035 are generic chest pain codes which are unlikely to indicate ischaemic heart disease.E139 and E149 not included in 'diabetes complications' as both codes specify '\...without complications'.Mental health admissions (with the exception of 'dementia') are excludes as they are not relevant to the evaluation sites that are collecting admission data. The excluded conditions are 'deliberate self-harm', 'neuroses' and 'schizophrenia'. 'Dementia' is relevant to two pilot sites, and so is retained.'Stroke' is excluded because of the substantial change seen in the admission criteria for stroke over the study period.O15 is excluded from 'convulsions and epilepsy' as the condition---eclampsia (a specific disorder of pregnancy)---is unrelated, except for the common symptom of fits.There are also some additional codes included: I129, I139, I132 and A082 are introduced by the process of converting the AHRQ codes from ICD-9CM to ICD-10.All cystitis codes (N30) are included in 'urinary tract infection', supplementing N300, N308 and N309.

###### 

Summary of the evidence on the effectiveness of interventions to improve coordination in health care, from Powell Davies et al. \[[@r2]\]

  Main focus of intervention                                                                                                                                                                                                                                                                                                              Proportion (%) of studies with positive outcome for health   Proportion (%) of studies with positive outcome for health/social care service user satisfaction   Proportion (%) of studies with positive outcome for cost saving
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------ -------------------------------------------------------------------------------------------------- -----------------------------------------------------------------
  *Changed relationships between service providers* Structured relationships between service providers including co-location, case management, multi-disciplinary teams or assigning health/social care service users to a particular PHC provider (33 studies)                                                                           19/29 (65.5%)                                                8/12 (66.7%)                                                                                       2/12 (16.7%)
  *Coordination of clinical activities* Using structured arrangements for coordinating service provision between providers, including joint consultations, shared assessments and priority access to another clinical service (37 studies)                                                                                                19/31 (61.3%)                                                4/12 (33.3%)                                                                                       3/15 (20%)
  *Improving communication between service providers* Interventions designed to improve communication between service providers, *e.g.* case conferences (56 studies)                                                                                                                                                                     26/47 (55.3%)                                                12/22 (54.5%)                                                                                      2/21 (14.3%)
  *Support for clinicians* Interventions include support or supervision for clinicians, training (joint or relating to collaboration), and reminder systems (33 studies)                                                                                                                                                                  16/28 (57.1%)                                                8/14 (57.1%)                                                                                       1/12 (8.3%)
  *Information systems to support co-ordination* Using information systems to support the coordination of care, including care plans; decision support, proformas; health/social care service user held or shared records; shared information or communication systems; and a register of health/social care service users (47 studies)   23/38 (60.5%)                                                7/19 (36.8%)                                                                                       2/13 (15.4%)
  *Support for health/social care service users* Interventions include education, reminders and assistance in accessing care (19 studies)                                                                                                                                                                                                 6/17 (35.3%)                                                 3/6 (50.0%)                                                                                        1/7 (14.3%)
  All studies                                                                                                                                                                                                                                                                                                                             36/65 (55.4%)                                                14/31 (45.2%)                                                                                      5/28 (17.9%)
